Max Healthcare Institute Limited has informed the Exchange regarding grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare's Nomination and Remuneration Committee approved the grant of 2,00,580 stock options to eligible employees under the company's ESOP 2022 scheme on August 12, 2025. Each option is convertible into one equity share of face value ₹10, at an exercise price of ₹900 per option. The options will vest over a period of 1 to 5 years from the grant date, subject to certain conditions. Employees will have 3 years from each vesting date to exercise the options. The scheme is compliant with SEBI's Share Based Employee Benefits and Sweat Equity Regulations, 2021.
This is a routine employee compensation event causing a minor equity dilution of 2,00,580 shares. The ₹900 exercise price gives employees skin in the game, aligning their interests with shareholders. No immediate material impact on stock price is expected.